CHRONIC NITRIC OXIDE INHIBITION AGGRAVATES HYPERTENSION IN ERYTHROPOIETIN-TREATED RENAL FAILURE RATS

REFERENCES

• Buckner F S, Eschbach J W, Haley N R, Davidson R C, Adamson J W. Hypertension following erythropoietin therapy in anemic hemodialysis patients. Am J Hypertens 1990; 3: 947–955
   PubMed Web of Science ®Google Scholar
• Abraham P A, Macres M G. Blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin. J Am Soc Nephrol 1991; 2: 927–936
   PubMed Web of Science ®Google Scholar
• Lebel M, Kingma I, Grose J H, Langlois S. Effect of recombinant human erythropoietin therapy on ambulatory blood pressure in normotensive and in untreated borderline hypertensive hemodialysis patients. Am J Hypertens 1994; 9: 545–551
   Google Scholar
• Lebel M, Kingma I, Grose J H, Langlois S. Hemodynamic and hormonal changes during erythropoietin therapy in hemodialysis patients. J Amer Soc Nephrol 1998; 9: 97–104
   PubMed Web of Science ®Google Scholar
• Ludwig H, Fritz E, Kotzmann H, Höcker P, Gesslinger M, Barnes U. Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 1990; 322: 1693–1699
   PubMed Web of Science ®Google Scholar
• Pincus T, Olsen N J, Russell J, Wolfe F, Harris E R, Schnitzer T J, Boccagno J H, Krantz S B. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med 1990; 89: 161–168
   PubMed Web of Science ®Google Scholar
• Fischl M, Galpin J E, Levine J D, Groopman J E, Henry D H, Kennedy P, Miles S, Robbins W, Starrett B, Zalusky R, Abel R I, Tsai H, Rudnick S A. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 1990; 322: 1488–1493
   PubMed Web of Science ®Google Scholar
• Berglund B, Ekblom B. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men. J Intern Med 1991; 229: 125–130
   PubMed Web of Science ®Google Scholar
• Lacasse-M S, Kingma I, Larivière R, Grose J H, Lebel M. Uremia enhances the blood pressure response to erythropoietin. Clin Exper Hypertension 1997; 19: 389–401
   PubMed Web of Science ®Google Scholar
• Muntzel M, Hannedouche T, Lacour B, Drüeke T B. Erythropoietin increases blood pressure in normotensive and hypertensive rats. Nephron 1993; 65: 601–604
   PubMed Web of Science ®Google Scholar
• Vaziri N D, Zhou X J, Smith J, Oveisi F, Baldwin K, Purdy R E. In vivo and in vitro pressor effects of erythropoietin in rats. Am J Physiol 1995; 269(Renal Fluid Electrolyte Physiol 38)F838–F845
   PubMedGoogle Scholar
• Hori K, Onoyama K, Iseki K, Fujimi S, Fujishima M. Hemodynamic and volume changes by recombinant human erythropoietin in the treatment of anemic hemodialysis patients. Clin Nephrol 1990; 33: 293–298
   PubMed Web of Science ®Google Scholar
• Heidenreich S, Rahn K-H, Zidek W. Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels. Kidney Int 1991; 39: 259–265
   PubMed Web of Science ®Google Scholar
• Eggena P, Willsey P, Jamgotchian N, Truckenbrod L, Hu M S, Barrett J D, Eggena M P, Clegg K, Nakhoul F, Lee D BN. Influence of recombinant human erythropoietin on blood pressure and renin-angiotensin systems. Am J Physiol 1991; 261: E642–E646
   PubMed Web of Science ®Google Scholar
• Vaziri N D, Zhou X J, Naqvi F, Smith J, Oveisi F, Wang Z Q, Purdy R E. Role of nitric oxide resistance in erythropoietin-induced hypertension in rats with chronic renal failure. Am J Physiol 1996; 271(Endocrinol Metab 34)E113–E122
   PubMedGoogle Scholar
• Anagnostou A, Liu Z, Steiner M, Chin K, Lee E S, Kessimian N, Noguchi C T. Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 1994; 91: 3974–3978
   PubMed Web of Science ®Google Scholar
• Carlini P G, Dusso A S, Obialo C I, Alvarez U M, Rothstein M. Recombinant human erythropoietin increases endothelin-1 release by endothelial cells. Kidney Int 1993; 43: 1010–1014
   PubMed Web of Science ®Google Scholar
• Bode-Böger S M, Böger R H, Kuhn M, Radermachis J, Förlich J C. Recombinant human erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoids. Kidney Int 1996; 50: 1255–1261
   PubMed Web of Science ®Google Scholar
• Lebel M, Lacasse-M S, Larivière R, Kingma I, Grose J H. Plasma and blood vessel endothelin-1 concentrations in hypertensive uremic rats treated with erythropoietin. Clin Exper Hypertens 1998; 20: 939–951
   PubMed Web of Science ®Google Scholar
• Brochu E, Lacasse-M S, Larivière R, Kingma I, Grose J H, Lebel M. Differential effects of endothelin-1 antagonists on erythropoietin-induced hypertension in renal failure. J Am Soc Nephrol, 1999, in press
   PubMedGoogle Scholar
• Del D Castillo, Raij L, Schultz P J, Tolins J P. The pressor effect of recombinant human erythropoietin is not due to decreased activity of the endogenous nitric oxide system. Nephrol Dial Transplant 1995; 10: 505–508
   PubMed Web of Science ®Google Scholar
• Tsukahara H, Hiraoka M, Hori C, Hata I, Okada T, Gejyo F, Sudo M. Chronic erythropoietin treatment enhances endogenous nitric oxide production in rats. Scand J Clin Lab Invest 1997; 57: 487–494
   PubMed Web of Science ®Google Scholar
• Wilcox C S, Deng X, Doll A H, Snellen H, Welch W J. Nitric oxide mediates renal vasodilation during erythropoietin-induced polycythemia. Kidney Int 1993; 44: 430–435
   PubMed Web of Science ®Google Scholar
• D'Amours M, Lebel M, Grose J H, Larivière R. Renal and vascular effects of chronic nitric oxide synthase inhibition involvement of endothelin-1 and angiotensin II. Can J Physiol Pharmacol 1999; 77: 8–16
   PubMed Web of Science ®Google Scholar
• Lebel M, Grose J H, Kingma I, Langlois S:. Plasma endothelin levels and blood pressure in hemodialysis and in CAPD patients. Effect of subcutaneous erythropoietin replacement therapy. Clin Exper Hypertens (A) 1994; 16: 565–575
   PubMed Web of Science ®Google Scholar
• Larivière R, D'Amours M, Lebel M, Kingma I, Grose J H, Caron L:. Increased immunoreactive endothelin-1 levels in blood vessels and glomeruli of rats with reduced renal mass. Kidney Blood Pressure Res 1997; 20: 372–380
   PubMed Web of Science ®Google Scholar
• Baylis C, Mitruka B, Deng A:. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992; 90: 278–281
   PubMed Web of Science ®Google Scholar
• Aisaka K, Gross S S, Griffith O W, Levi R. NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo. Biochem Biophys Res Commun 1989; 160: 881–886
   PubMed Web of Science ®Google Scholar
• Fujihara C K, De G Nucci, Zatz R. with the technical participation of Michelazzo SM and Miristeni dos Santos M: Chronic nitric oxide synthase inhibition aggravates glomerular injury in rats with subtotal nephrectomy. J Am Soc Nephrol 1995; 5: 1498–1507
   PubMed Web of Science ®Google Scholar
• Ni Z, Wang X Q, Vaziri N D:. Nitric oxide metabolism in erythropoietin-induced hypertension. Effect of calcium channel blockade. Hypertension 1998; 32: 724–729
   PubMed Web of Science ®Google Scholar
• Wang X Q, Vaziri N D:. Erythropoietin depresses nitric oxide synthase expression by human endothelial cells. Hypertension 1999; 33: 894–899
   PubMed Web of Science ®Google Scholar
• Poux J-M, Lartigue M, Chaisemartin R-A, Galen F X, Leroux-Robert C. Uraemia is necessary for erythropoietin-induced hypertension in rats. Clin Exper Pharmacol Physiol 1995; 22: 769–771
   PubMed Web of Science ®Google Scholar
• Arnal J F, Warin L, Michel J B. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthetase. J Clin Invest 1992; 90: 647–652
   PubMed Web of Science ®Google Scholar
• Li J-S, Deng L Y, Grove K, Deschepper C F, Schiffrin E L. Comparison of effect of endothelin antagonism and angiotensin-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester: Correlation with topography of vascular endothelin-1 gene expression. Hypertension 1996; 28: 188–195
   PubMed Web of Science ®Google Scholar
• Yoshizumi M, Kurihara H, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, Yazaki Y. Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem Biophys Res Commun 1989; 161: 859–864
   PubMed Web of Science ®Google Scholar